Ken Griffin Options Holdings

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
EDV
Vanguard Extended Duration Tre

ETFs
CALL
$262,000
3.9K
Q2 2025
Reduced 83.55%
EDV
Vanguard Extended Duration Tre

ETFs
PUT
$679,000
10.1K
Q2 2025
Reduced 83.55%
MGK
Vanguard Mega Cap Growth ETF

ETFs
CALL
$4.17 Million
11.4K
Q2 2025
Reduced 15.56%
MGK
Vanguard Mega Cap Growth ETF

ETFs
PUT
$2.34 Million
6.4K
Q2 2025
Reduced 15.56%
MGV
Vanguard Mega Cap Value

ETFs
CALL
$275,000
2.1K
Q2 2025
Added 950.0%
VCR
Vanguard Consumer Discretionar

ETFs
CALL
$905,000
2.5K
Q2 2025
Reduced 73.68%
VCR
Vanguard Consumer Discretionar

ETFs
PUT
$362,000
1K
Q2 2025
Reduced 73.68%
VDE
Vanguard Energy ETF

ETFs
CALL
$2.22 Million
18.6K
Q2 2025
Added 25.0%
VDE
Vanguard Energy ETF

ETFs
PUT
$1.37 Million
11.5K
Q2 2025
Added 25.0%
VFH
Vanguard Financial ETF

ETFs
CALL
$1.09 Million
8.6K
Q2 2025
Reduced 63.09%
VPU
Vanguard Utilities ETF

ETFs
CALL
$1.45 Million
8.2K
Q2 2025
Added 287.5%
VPU
Vanguard Utilities ETF

ETFs
PUT
$1.09 Million
6.2K
Q2 2025
Added 287.5%
VREX
Varex Imaging Corp

Healthcare
CALL
$105,000
12.2K
Q2 2025
Added 1860.0%
VREX
Varex Imaging Corp

Healthcare
PUT
$679,000
78.4K
Q2 2025
Added 1860.0%
VRNS
Varonis Systems Inc

Technology
CALL
$1.71 Million
33.6K
Q2 2025
Added 61.18%
VRNS
Varonis Systems Inc

Technology
PUT
$2.78 Million
54.8K
Q2 2025
Added 61.18%
VXRT
Vaxart, Inc.

Healthcare
CALL
$22,000
50.3K
Q2 2025
Added 251.75%
PCVX
Vaxcyte, Inc.

Healthcare
CALL
$2.7 Million
83K
Q2 2025
Added 73.63%
PCVX
Vaxcyte, Inc.

Healthcare
PUT
$1.03 Million
31.6K
Q2 2025
Added 73.63%
VECO
Veeco Instruments Inc

Technology
CALL
$469,000
23.1K
Q2 2025
Reduced 54.56%
VECO
Veeco Instruments Inc

Technology
PUT
$729,000
35.9K
Q2 2025
Reduced 54.56%
VEEV
Veeva Systems Inc

Healthcare
PUT
$23.9 Million
83K
Q2 2025
Reduced 26.16%
VEL
Velocity Financial, Inc.

Financial Services
CALL
$352,000
19K
Q2 2025
Reduced 32.44%
VEL
Velocity Financial, Inc.

Financial Services
PUT
$1.54 Million
83.3K
Q2 2025
Reduced 32.44%
VTR
Ventas, Inc.

Real Estate
CALL
$3.54 Million
56.1K
Q2 2025
Reduced 36.85%
VTR
Ventas, Inc.

Real Estate
PUT
$4.16 Million
65.8K
Q2 2025
Reduced 36.85%
Venture Global Inc
CALL
$0
536K
Q2 2025
Added 76.52%
Venture Global Inc
PUT
$0
461K
Q2 2025
Added 76.52%
VTYX
Ventyx Biosciences, Inc.

Healthcare
CALL
$92,000
43K
Q2 2025
Reduced 10.75%
VTYX
Ventyx Biosciences, Inc.

Healthcare
PUT
$40,000
19.1K
Q2 2025
Reduced 10.75%
Veon LTD
PUT
$0
24.3K
Q2 2025
Reduced 10.33%
VERA
Vera Therapeutics, Inc.

Healthcare
CALL
$949,000
40.3K
Q2 2025
Added 763.33%
VERA
Vera Therapeutics, Inc.

Healthcare
PUT
$1.83 Million
77.7K
Q2 2025
Added 763.33%
Veralto Corp
CALL
$0
15.9K
Q2 2025
Added 94.86%
Veralto Corp
PUT
$0
8.35K
Q2 2025
Added 94.86%
Verastem Inc
CALL
$0
36.8K
Q2 2025
Reduced 9.85%
Verastem Inc
PUT
$0
18.3K
Q2 2025
Reduced 9.85%
VCEL
Vericel Corp

Healthcare
CALL
$306,000
7.2K
Q2 2025
Reduced 50.0%
VRNT
Verint Systems Inc

Technology
CALL
$880,000
27K
Q2 2025
Reduced 22.94%
VRNT
Verint Systems Inc

Technology
PUT
$2.1 Million
64.5K
Q2 2025
Reduced 22.94%
VRE
Veris Residential, Inc.

Real Estate
PUT
$2.61 Million
175K
Q2 2025
Added 34900.0%
VRSN
Verisign Inc

Technology
CALL
$9.36 Million
32.4K
Q2 2025
Reduced 1.95%
VRSK
Verisk Analytics, Inc.

Industrials
CALL
$7.07 Million
22.7K
Q2 2025
Added 10.84%
VRSK
Verisk Analytics, Inc.

Industrials
PUT
$2.87 Million
9.2K
Q2 2025
Added 10.84%
VERI
Veritone, Inc.

Technology
CALL
$138,000
110K
Q2 2025
Reduced 90.16%
VERI
Veritone, Inc.

Technology
PUT
$17,000
13.8K
Q2 2025
Reduced 90.16%
VET
Vermilion Energy Inc.

Energy
CALL
$2.83 Million
388K
Q2 2025
Reduced 31.89%
VET
Vermilion Energy Inc.

Energy
PUT
$435,000
59.8K
Q2 2025
Reduced 31.89%
VRNA
Verona Pharma PLC

Healthcare
CALL
$11.4 Million
120K
Q2 2025
Reduced 11.49%
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio

Summary

  • Portfolio
  • No. of Stocks 15,124
  • Current Value $550 Billion
  • Prior Value $509 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1,309 stocks
  • Additional Purchases 2,297 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2,137 stocks
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email